5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.34▼ | 1.34▼ | 1.34▼ | 1.30▲ | 1.13▲ |
MA10 | 1.34▼ | 1.34▼ | 1.34▼ | 1.23▲ | 1.21▲ |
MA20 | 1.35▼ | 1.33▲ | 1.30▲ | 1.12▲ | 1.38▼ |
MA50 | 1.32▲ | 1.29▲ | 1.27▲ | 1.22▲ | 2.38▼ |
MA100 | 1.29▲ | 1.23▲ | 1.16▲ | 1.44▼ | 3.67▼ |
MA200 | 1.27▲ | 1.12▲ | 1.16▲ | 2.29▼ | 5.64▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.003▼ | 0.000▲ | 0.039▲ | 0.059▲ |
RSI | 45.384▼ | 53.689▲ | 57.672▲ | 58.235▲ | 40.866▼ |
STOCH | 25.000 | 23.333 | 63.459 | 83.389▲ | 25.020 |
WILL %R | -100.000▼ | -80.000▼ | -23.529▲ | -14.286▲ | -64.468 |
CCI | -157.246▼ | -71.795 | 30.772 | 110.837▲ | -0.023 |
CDL | $PDSB Marubozu Candlestick Pattern Detected | Set Alert |
Tuesday, April 22, 2025 05:00 PM
PRINCETON, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy ...
|
Wednesday, April 16, 2025 07:01 AM
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
|
Friday, April 11, 2025 02:22 PM
NCI presentation to highlight IL-12 fused antibody drug conjugate during poster presentation PRINCETON, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 1.40 | 1.40 | 1.32 | 1.33 | 88,944 |
30/04/25 | 1.24 | 1.40 | 1.20 | 1.40 | 278,767 |
29/04/25 | 1.24 | 1.285 | 1.22 | 1.265 | 99,957 |
28/04/25 | 1.23 | 1.29 | 1.21 | 1.24 | 185,105 |
25/04/25 | 1.29 | 1.3399 | 1.24 | 1.25 | 177,828 |
24/04/25 | 1.23 | 1.325 | 1.22 | 1.32 | 264,853 |
23/04/25 | 1.18 | 1.268 | 1.165 | 1.23 | 357,000 |
22/04/25 | 1.09 | 1.16 | 1.07 | 1.15 | 172,317 |
21/04/25 | 1.07 | 1.1353 | 1.06 | 1.08 | 237,275 |
17/04/25 | 1.05 | 1.11 | 1.03 | 1.08 | 131,526 |
|
|
||||
|
|
||||
|
|